Business
H&R GmbH & Co. KGaA: Preliminary results for Q1/2025 published
H&R GmbH & Co. KGaA: Preliminary results for Q1/2025
About this update from H&r Gmbh & Co. Kgaa
[{"type":"text","content":"\nEQS-Ad-hoc: H&R GmbH & Co. KGaA / Key word(s): Quarter Results/Preliminary Results\n\n H&R GmbH & Co. KGaA: Preliminary results for Q1/2025 published \n30-Apr-2025 / 15:52 CET/CEST\n\nDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.\n\nThe issuer is solely responsible for the content of this announcement.Insider information pursuant to Article 17 of the Market Abuse Regulation [MAR]H&R GmbH & Co. KGaA: Preliminary results for Q1/2025 published Results in Q1-2025 slightly improved compared to previous year EBITDA of EUR 22.4 million (Q1-2024: EUR 21.3 million) a good 5% above the same quarter of year 2024Salzbergen, Germany, April 30, 2025. H&R GmbH & Co. KGaA (H&R KGaA for short; DE000A2E4T77) achieved an operating result (EBITDA - consolidated earnings before income taxes, other financial income and expenses as well as amortization, depreciation and impairment losses and reversals of impairment losses on intangible assets and property, plant and equipment) of EUR 22.4 million in the first quarter of 2025 (Q1/2024: EUR 21.3 million), slightly above the level of the same quarter of the previous year, according to preliminary calculations.\n\nBased on slightly higher sales revenue compared to the previous year, the improved performance is reflected across all earnings levels. EBIT amounted to EUR 7.7 million (Q1/2024: EUR 6.8 million) and earnings before taxes (EBT) to EUR 4.7 million (Q1/2024: EUR 3.6 million). At the bottom line, the Group achieved an improved result attributable to its shareholders of EUR 1.9 million compared to the same quarter of the previous year (Q1/2024: EUR 1.5 million). This was achieved with sales revenues of EUR 345.8 million, around 2.6% more than in the previous year (Q1/2024: EUR 337.0 million). Overall, we recorded robust demand in the first quarter of 2025. Product prices and quotations were also in line with our expectations at the start of the year. The latter brightened somewhat compared to the end of the previous year and made it easier for us to negotiate prices with buyers in our customer industries to some extent.Segment ChemPharm Refining significantly improved\n\nThe development of the segments presents a different picture than a year ago. While the Group's...